本页面由Tiger Trade Technology Pte. Ltd.提供服务

Skye Bioscience Inc.

0.7500
-0.0230-2.98%
盘后0.7481-0.0019-0.25%17:32 EDT
成交量:24.16万
成交额:18.41万
市值:2,503.41万
市盈率:-0.53
高:0.7999
开:0.7940
低:0.7401
收:0.7730
52周最高:5.75
52周最低:0.5655
股本:3,337.88万
流通股本:1,988.22万
量比:1.43
换手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):-1.4100
每股收益(LYR):-1.4100
净资产收益率:-126.85%
总资产收益率:-71.93%
市净率:1.25
市盈率(LYR):-0.53

数据加载中...

2021/07/26

重要事件披露

8-K - Current report
2021/07/22

重要事件披露

8-K - Current report
2021/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/02

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

重要事件披露

8-K - Current report
2021/01/19

重要事件披露

8-K - Current report
2020/11/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/09/28

重要事件披露

8-K - Current report
2020/08/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/13

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/08/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/12

重要事件披露

8-K - Current report
2020/08/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/05

重要事件披露

8-K - Current report
2020/07/29

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/28

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/13

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933